This subgroup also exhibited higher leukocyte counts and high-sensitivity C-reactive protein.<h4>Conclusion</h4>CitH<sub>3</sub> alone was not predictive of adverse events in stable CAD. The gene discussed is CRP; the disease is coronary artery disorder.